Literature DB >> 29643065

Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.

Emmanouil Tampakakis1, Sanjiv J Shah1, Barry A Borlaug1, Peter J Leary1, Harnish H Patel1, Wayne L Miller1, Benjamin W Kelemen1, Brian A Houston1, Todd M Kolb1, Rachel Damico1, Stephen C Mathai1, Edward K Kasper1, Paul M Hassoun1, David A Kass1, Ryan J Tedford2.   

Abstract

BACKGROUND: Patients with combined post- and precapillary pulmonary hypertension due to left heart disease have a worse prognosis compared with isolated postcapillary. However, it remains unclear whether increased mortality in combined post- and precapillary pulmonary hypertension is simply a result of higher total right ventricular load. Pulmonary effective arterial elastance (Ea) is a measure of total right ventricular afterload, reflecting both resistive and pulsatile components. We aimed to test whether pulmonary Ea discriminates survivors from nonsurvivors in patients with pulmonary hypertension due to left heart disease and if it does so better than other hemodynamic parameters associated with combined post- and precapillary pulmonary hypertension. METHODS AND
RESULTS: We combined 3 large heart failure patient cohorts (n=1036) from academic hospitals, including patients with pulmonary hypertension due to heart failure with preserved ejection fraction (n=232), reduced ejection fraction (n=335), and a mixed population (n=469). In unadjusted and 2 adjusted models, pulmonary Ea more robustly predicted mortality than pulmonary vascular resistance and the transpulmonary gradient. Along with pulmonary arterial compliance, pulmonary Ea remained predictive of survival in patients with normal pulmonary vascular resistance. The diastolic pulmonary gradient did not predict mortality. In addition, in a subset of patients with echocardiographic data, Ea and pulmonary arterial compliance were better discriminators of right ventricular dysfunction than the other parameters.
CONCLUSIONS: Pulmonary Ea and pulmonary arterial compliance more consistently predicted mortality than pulmonary vascular resistance or transpulmonary gradient across a spectrum of left heart disease with pulmonary hypertension, including patients with heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, and pulmonary hypertension with a normal pulmonary vascular resistance.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  heart failure; pulmonary hypertension; stroke volume; survivors; vascular resistance

Mesh:

Year:  2018        PMID: 29643065      PMCID: PMC5901761          DOI: 10.1161/CIRCHEARTFAILURE.117.004436

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  33 in total

1.  Systolic pulmonary artery pressure and heart rate are main determinants of oxygen consumption in the right ventricular myocardium of patients with idiopathic pulmonary arterial hypertension.

Authors:  Yeun Ying Wong; Nico Westerhof; Gerrina Ruiter; Mark Lubberink; Pieter Raijmakers; Paul Knaapen; J Tim Marcus; Anco Boonstra; Adriaan A Lammertsma; Willem J van der Laarse; Anton Vonk-Noordegraaf
Journal:  Eur J Heart Fail       Date:  2011-10-20       Impact factor: 15.534

2.  Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction.

Authors:  Nadine Al-Naamani; Ioana R Preston; Jessica K Paulus; Nicholas S Hill; Kari E Roberts
Journal:  JACC Heart Fail       Date:  2015-06       Impact factor: 12.035

Review 3.  Pulmonary hypertension due to left heart disease.

Authors:  Marco Guazzi; Barry A Borlaug
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

4.  Pulmonary capillary wedge pressure augments right ventricular pulsatile loading.

Authors:  Ryan J Tedford; Paul M Hassoun; Stephen C Mathai; Reda E Girgis; Stuart D Russell; David R Thiemann; Oscar H Cingolani; James O Mudd; Barry A Borlaug; Margaret M Redfield; David J Lederer; David A Kass
Journal:  Circulation       Date:  2011-11-30       Impact factor: 29.690

5.  The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease.

Authors:  Emmanouil Tampakakis; Peter J Leary; Van N Selby; Teresa De Marco; Thomas P Cappola; G Michael Felker; Stuart D Russell; Edward K Kasper; Ryan J Tedford
Journal:  JACC Heart Fail       Date:  2014-11-12       Impact factor: 12.035

6.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

Authors:  Christian Gerges; Mario Gerges; Marie B Lang; Yuhui Zhang; Johannes Jakowitsch; Peter Probst; Gerald Maurer; Irene M Lang
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

7.  Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.

Authors:  Barry A Borlaug; Vojtech Melenovsky; Katlyn E Koepp
Journal:  Circ Res       Date:  2016-07-25       Impact factor: 17.367

8.  RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension.

Authors:  Rebecca R Vanderpool; Michael R Pinsky; Robert Naeije; Christopher Deible; Vijaya Kosaraju; Cheryl Bunner; Michael A Mathier; Joan Lacomis; Hunter C Champion; Marc A Simon
Journal:  Heart       Date:  2014-09-11       Impact factor: 5.994

9.  Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure.

Authors:  Wayne L Miller; Diane E Grill; Barry A Borlaug
Journal:  JACC Heart Fail       Date:  2013-08-05       Impact factor: 12.035

10.  Heart Rate Dependence of the Pulmonary Resistance x Compliance (RC) Time and Impact on Right Ventricular Load.

Authors:  Thomas S Metkus; Christopher J Mullin; E Wilson Grandin; J Eduardo Rame; Emmanouil Tampakakis; Steven Hsu; Todd M Kolb; Rachel Damico; Paul M Hassoun; David A Kass; Stephen C Mathai; Ryan J Tedford
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

View more
  20 in total

1.  Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation.

Authors:  Takeo Fujino; Aline Sayer; Daisuke Nitta; Teruhiko Imamura; Nikhil Narang; Ann Nguyen; Daniel Rodgers; Jayant Raikhelkar; Bryan Smith; Gene Kim; Colleen LaBuhn; Valluvan Jeevanandam; Daniel Burkhoff; Gabriel Sayer; Nir Uriel
Journal:  J Card Fail       Date:  2020-02-03       Impact factor: 5.712

Review 2.  Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Authors:  George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

Review 3.  Pulmonary Hypertension in the Context of Heart Failure With Preserved Ejection Fraction.

Authors:  Chakradhari Inampudi; Daniel Silverman; Marc A Simon; Peter J Leary; Kavita Sharma; Brian A Houston; Jean-Luc Vachiéry; Francois Haddad; Ryan J Tedford
Journal:  Chest       Date:  2021-08-12       Impact factor: 9.410

Review 4.  The Mechanobiology of Vascular Remodeling in the Aging Lung.

Authors:  Paul B Dieffenbach; Aja Aravamudhan; Laura E Fredenburgh; Daniel J Tschumperlin
Journal:  Physiology (Bethesda)       Date:  2021-09-13

5.  Nonplatelet thromboxane generation is associated with impaired cardiovascular performance and mortality in heart failure.

Authors:  Essa Hariri; Nikolaos Kakouros; David A Bunsick; Stuart D Russell; James O Mudd; Katherine Laws; Mikhailia W Lake; Jeffrey J Rade
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-06-17       Impact factor: 5.125

Review 6.  Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.

Authors:  Bradley A Maron; Gabor Kovacs; Anjali Vaidya; Deepak L Bhatt; Rick A Nishimura; Susanna Mak; Marco Guazzi; Ryan J Tedford
Journal:  J Am Coll Cardiol       Date:  2020-12-01       Impact factor: 24.094

Review 7.  Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction.

Authors:  Andrea R Levine; Marc A Simon; Mark T Gladwin
Journal:  Trends Cardiovasc Med       Date:  2018-08-17       Impact factor: 6.677

8.  Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation.

Authors:  Gaurav Gulati; Robin Ruthazer; David Denofrio; Amanda R Vest; David Kent; Michael S Kiernan
Journal:  J Card Fail       Date:  2021-01-12       Impact factor: 5.712

9.  Hemodynamic Characteristics and Outcomes of Pulmonary Hypertension in Patients Undergoing Tricuspid Valve Repair or Replacement.

Authors:  Mahima Vijayaraghavan; Kurt W Prins; Sasha Z Prisco; Sue Duval; Ranjit John; Stephen L Archer; E Kenneth Weir; Rochus Voeller; Andrew W Shaffer; Thenappan Thenappan
Journal:  CJC Open       Date:  2020-12-16

10.  Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.

Authors:  Bradley A Maron; Steven H Abman; C Greg Elliott; Robert P Frantz; Rachel K Hopper; Evelyn M Horn; Mark R Nicolls; Oksana A Shlobin; Sanjiv J Shah; Gabor Kovacs; Horst Olschewski; Erika B Rosenzweig
Journal:  Am J Respir Crit Care Med       Date:  2021-06-15       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.